NCT02998437View on ClinicalTrials.gov

Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Clarithromycin, Amoxicillin and Ilaprazole

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Drug Interaction Potentiation
Interventions
DRUG

Ilaprazole 10mg

Period 1: Ilaprazole 10mg, one a day, one day Period 2: Ilaprazole 10mg, twice a day, 6 days

DRUG

Clarithromycin 500mg

Period 1: Clarithromycin 500mg 1 tab., twice a day, one day Period 2: Clarithromycin 500mg 1 tab., one a day at 5 day

DRUG

Amoxicillin 500 Mg

Period 1: Amoxicillin 500mg 2 cap., one a day, one day Period 2: Amoxicillin 500mg 2 cap., one a day at 5 day

Trial Locations (1)

Unknown

Severance Hospital, Seoul

All Listed Sponsors
collaborator

Severance Hospital

OTHER

lead

Il-Yang Pharm. Co., Ltd.

INDUSTRY

NCT02998437 - Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Clarithromycin, Amoxicillin and Ilaprazole | Biotech Hunter | Biotech Hunter